Be part of the knowledge.™

Thimerosal Safety - Should We Still Be Concerned?

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
In this segment host Bill Rutenberg questions William Thompson, Ph.D., lead author of the recent CDC Thimerosal study about some of the doubts critics of the study still have about the neuropsychological impacts of Thimerosal.

William Thompson, PhD

William Thompson, PhD

Bill Rutenberg, MD

Bill Rutenberg, MD

Recommended

Details

Presenters

Overview
In this segment host Bill Rutenberg questions William Thompson, Ph.D., lead author of the recent CDC Thimerosal study about some of the doubts critics of the study still have about the neuropsychological impacts of Thimerosal.

William Thompson, PhD

William Thompson, PhD

Bill Rutenberg, MD

Bill Rutenberg, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue

$IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement$

IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement

IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy

IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis

Diagnosis and Management of Metastatic PDAC

HF Management for Patients with Comorbid Conditions

Level Up Your Skills: Tailoring Management of HF

FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure